Jim Kim

ORCID: 0000-0003-4466-5517
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Liver Disease and Transplantation
  • Organ Donation and Transplantation
  • Transplantation: Methods and Outcomes
  • T-cell and B-cell Immunology
  • Pancreatitis Pathology and Treatment
  • DNA and Nucleic Acid Chemistry
  • Hepatitis B Virus Studies
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Liver physiology and pathology
  • Cytomegalovirus and herpesvirus research
  • HIV, Drug Use, Sexual Risk
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • Hemoglobinopathies and Related Disorders
  • COVID-19 and healthcare impacts
  • COVID-19 Impact on Reproduction
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Peroxisome Proliferator-Activated Receptors
  • Porphyrin Metabolism and Disorders
  • Dialysis and Renal Disease Management

University of Southern California
2020-2025

Second Military Medical University
2020

Keck Hospital of USC
2020

GTx (United States)
2020

Eastern Hepatobiliary Surgery Hospital
2020

Weill Cornell Medicine
2017

Kettering Medical Center
2017

Cornell University
2013-2017

University of Wisconsin–Madison
2011

University of California, San Francisco
2007-2008

Background. The Centers for Disease Control and Prevention (CDC) recommends 1-time hepatitis C virus (HCV) testing in the 1945–1965 birth cohort, addition to targeted risk-based testing. Emergency departments (EDs) are key venues HCV because of population served success HIV screening. We determined burden undocumented infection our ED, providing guidance implementation ED-based

10.1093/cid/ciw074 article EN Clinical Infectious Diseases 2016-02-21

Although the linkage between innate and adaptive immunity in transplantation has been recognized, mechanisms underlying this cooperation remain to be fully elucidated. In study, we show that early "danger" signals associated with lead rapid up-regulation of NKG2D ligands. A second wave ligand is mediated by immune response allografts. Treatment an Ab was highly effective preventing CD28-independent rejection cardiac Notably, blockade did not deplete CD8(+) T cells or NK1.1(+) nor affect...

10.4049/jimmunol.179.10.6416 article EN The Journal of Immunology 2007-11-15

(COVID-19) has resulted in significant morbidity and mortality solid organ transplant recipients. In December 2020, at the peak of Los Angeles outbreak, our center rapidly implemented a protocol to improve outpatient management provide bamlanivimab or casirivimab-imdevimab [COVID monoclonal antibody (mAb) therapies] all eligible COVID-19 positive liver kidney recipients.A retrospective review abdominal recipients who were polymerase chain reaction between February 2020 2021 from was...

10.1097/tp.0000000000003953 article EN Transplantation 2021-09-13

Background. T-cell receptor transgenic (TCR-tg) mouse models with direct CD4+ alloreactivity will help elucidate mechanisms of transplant rejection and tolerance in vivo. Although such exist, they are limited by unusual strain combinations or based on model antigens. Methods. A TCR-tg CD4 specificity the widely used BALB/c donor → C57BL/6 host combination was created. This mouse, named 4C, selected for reactivity against dendritic cells order to early priming events after transplantation....

10.1097/tp.0b013e31815e883e article EN Transplantation 2008-01-27

In kidney transplant recipients, delayed graft function (DGF) increases the risk of failure and mortality. a phase 3, randomized, double-blind, placebo-controlled trial, we investigated hepatocyte growth factor mimetic, ANG-3777 (once daily for 3 consecutive days, starting ≤30 hours posttransplant), in 248 patients receiving first from deceased donor. At day 360, estimated glomerular filtration rate (eGFR; primary endpoint) was not significantly different between placebo groups. There were...

10.1016/j.ajt.2024.02.014 article EN cc-by American Journal of Transplantation 2024-02-20

One-third of kidney transplantation patients experience acute injury (AKI) resulting in delayed graft function (DGF), associated with increased risk failure and mortality. Preclinical phase 2 data indicate that treatment ANG-3777 (formerly BB3), a hepatocyte growth factor (HGF) mimetic, may improve long-term reduce health care resource use cost, but these require validation 3 randomized controlled trial.The Graft Improvement Following Transplant (GIFT) trial is multicenter, double-blind...

10.1016/j.ekir.2020.11.001 article EN cc-by-nc-nd Kidney International Reports 2020-11-13

Biliary complications in liver transplantation (LT) can cause significant morbidity or even lead to a potential graft loss and patient mortality. Oftentimes biliary internal stents (ISs) are used at the time of LT lower risk for prevent these complications; however, their efficacy outcomes remain controversial. A retrospective cohort study was conducted on all adult patients who underwent deceased-donor (DDLT) with an end-to-end choledococholedocostomy. An IS placed across anastomosis,...

10.1016/j.transproceed.2020.06.019 article EN cc-by-nc-nd Transplantation Proceedings 2020-07-17

Little is known regarding the possible role of social network members and peer attitudes on emergency department (ED) patients' willingness to be tested for HIV. We conducted mixed methods in-depth interview quantitative survey with ED patients from November 2013 June 2014 assess personal perceptions ED-based HIV testing. Patients enrolled were asked about their own toward testing as well those friends. Interviews transcribed categories that captured free responses in verbatim independently...

10.1016/j.jiph.2019.07.005 article EN cc-by-nc-nd Journal of Infection and Public Health 2019-08-01
Coming Soon ...